(Q43519004)

24 November 2017

Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors? (English)

1 reference

24 November 2017

7

Dieter Flesch-Janys

1 reference

24 November 2017

6

Rudolf Kaaks

1 reference

24 November 2017

8

Jenny Chang-Claude

1 reference

24 November 2017

1

Alina Vrieling

1 reference

24 November 2017

2

Petra Seibold

1 reference

24 November 2017

4

Judith Heinz

1 reference

24 November 2017

5

Nadia Obi

1 reference

24 November 2017

3

Theron S Johnson

1 reference

PubMed ID

24272459

24 November 2017

language of work or name

English

0 references

publication date

7 December 2013

1 reference

International Journal of Cancer

24 November 2017

1 reference

24 November 2017

134

1 reference

24 November 2017

2972-2983

1 reference

24 November 2017

12

1 reference

Vitamin D status: measurement, interpretation, and clinical application

24 November 2017

1 reference

Meta-analysis: serum vitamin D and breast cancer risk

21 January 2018

1 reference

Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study

21 January 2018

1 reference

Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer

21 January 2018

1 reference

Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study

21 January 2018

1 reference

Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study

21 January 2018

1 reference

Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.

21 January 2018

1 reference

Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors

21 January 2018

1 reference

Serum 25-hydroxyvitamin D levels in early and advanced breast cancer

21 January 2018

1 reference

Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

21 January 2018

1 reference

Duration of physical activity and serum 25-hydroxyvitamin D status of postmenopausal women

21 January 2018

1 reference

Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women

21 January 2018

1 reference

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?

21 January 2018

1 reference

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients

21 January 2018

1 reference

High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy

21 January 2018

1 reference

Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer

21 January 2018

1 reference

Public health implications of standardized 25-hydroxyvitamin D levels: a decrease in the prevalence of vitamin D deficiency among older women in Germany

21 January 2018

1 reference

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28628

1 reference

24 November 2017

1 reference

PubMed ID

24272459